Captrust Financial Advisors Cor Medix Inc. Transaction History

Captrust Financial Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$2.73 - $5.61 $488 - $1,004	179 Added 11.93%	1,679 $7,000
Q4 2021 Feb 14, 2022	SELL	$4.47 - $5.56 $697 - $867	-156 Reduced 9.42%	1,500 $7,000
Q3 2021 Nov 16, 2021	SELL	$4.46 - $7.11 $3,501 - $5,581	-785 Reduced 32.16%	1,656 $8,000
Q2 2021 Aug 16, 2021	BUY	$6.05 - $10.09 $5,693 - $9,494	941 Added 62.73%	2,441 $17,000
Q1 2021 May 17, 2021	BUY	$6.84 - $17.58 $10,260 - $26,369	1,500 New	1,500 $15,000

123

18.6M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $427M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.